版本:
中国

BRIEF-Sunesis announces proposed public offering of common stock and preferred stock

Oct 18 Sunesis Pharmaceuticals Inc

* Sunesis announces proposed public offering of common stock and preferred stock

* Sunesis Pharmaceuticals Inc - Expects to use proceeds for clinical development of SNS-062, regulatory development of vosaroxin in Europe Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐